februari
follow
public
report
show
vitro
activ
cq
sever
acut
respiratori
syndrom
coronaviru
februari
state
council
china
held
news
confer
indic
chloroquin
cq
demonstr
efficaci
treat
associ
pneumonia
multicent
nonrandom
clinic
trial
prompt
multipl
clinic
trial
china
april
rd
gao
et
al
treat
patient
cq
report
control
inhibit
exacerb
pneumonia
improv
lung
imag
find
shorten
diseas
cours
detail
data
underli
claim
yet
publish
hydroxycholoroquin
hcq
analogu
cq
fewer
side
effect
better
safeti
profil
less
drug
interact
show
vitro
antivir
activ
sarscov
previou
sar
outbreak
yao
et
al
compar
vitro
activ
drug
find
hcq
superior
cq
recommend
hcq
sulfat
mg
twice
daili
day
follow
mg
twice
daili
next
day
treat
similar
vitro
result
report
wuhan
institut
virolog
epicent
shift
china
europ
colson
et
al
recommend
use
hcq
possibl
prophylaxi
cur
treatment
gautret
et
al
first
report
promis
vivo
data
hcq
nonrandom
clinic
trial
use
mg
hcq
three
time
day
day
plu
azithromycin
azm
deem
necessari
higher
frequenc
clearanc
notic
day
treatment
hcq
alon
hcqazm
versu
untreat
control
group
vs
p
azm
ad
hcq
significantli
effici
viru
elimin
find
rapidli
dissemin
lay
press
social
media
lead
endors
hcq
mani
govern
institut
leader
includ
presid
trump
refer
game
changer
demand
hcq
increas
exponenti
lead
overal
shortag
make
prescript
refil
challeng
march
st
medrxivorg
publish
data
first
complet
random
clinic
trial
wuhan
investig
efficaci
hcq
patient
patient
random
equal
two
group
treatment
group
receiv
oral
hcq
mgbid
day
articl
current
revis
report
signific
differ
time
clinic
recoveri
ttcr
radiolog
find
group
tabl
date
despit
enough
rational
justifi
investig
efficaci
safeti
hcq
tabl
evid
regard
effect
remain
limit
hcq
yet
receiv
fda
approv
use
trial
need
establish
guidelin
emerg
data
ongo
trial
establish
efficaci
hcq
prophylaxi
treatment
triag
import
ensur
exist
suppli
use
appropri
tabl
summar
antivir
mechan
action
cq
hcq
mechan
effect
halt
glycosyl
reduc
bind
spike
protein
coronaviru
host
cell
increas
endosom
lysosom
ph
prevent
fusion
viru
host
cell
subsequ
replic
prevent
antigen
process
mhciimedi
autoantigen
present
cell
reduc
cell
activ
express
cytokin
tnf
disrupt
interact
cytosol
viral
dnarna
tlr
nucleic
acid
sensor
cga
halt
transcript
proinflammatori
gene
attenu
possibl
cytokin
storm
type
interferon
tnf
hcq
abbrevi
angiotensin
convert
enzym
receptor
mhc
major
histocompat
complex
tlr
tolllik
receptor
cga
cyclic
gmpamp
synthas
il
interleukin
tnf
tumor
necrosi
factor
alpha
